CD276 and prostate cancer: Several studies reported the expression of B7-H3 in various types of human cancer cell lines and tissues, such as leukemia, colon cancer, lung cancer, melanoma, prostate cancer, urothelial cell cancer, renal cell cancer, gastric cancer, ovarian cancer, and neuroblastoma [16–20].